Inhibition of IL-8 and RANTES release from cultured human airway smooth muscle cells by fluticasone and budesonide Source: Eur Respir J 2002; 20: Suppl. 38, 384s Year: 2002
Budesonide prevents cytokine-induced decrease of the relaxant response to formoterol but not to salmeterol in mouse trachea Source: Annual Congress 2009 - Translational research/biomarkers Year: 2009
The long-acting β2-agonist formoterol re-establishes the anti-proliferative effect of glucocorticoids in asthmatic airway smooth muscle cells (ASMC) Source: Annual Congress 2011 - Understanding disease and drug mechanisms Year: 2011
Proliferation is not increased in airway myofibroblasts isolated from asthmatics Source: Eur Respir J 2008; 32: 362-371 Year: 2008
Synergistic anti-inflammatory effects of salmeterol and fluticasone on the release of IL-8 and MCP-1 by human bronchial epithelial cells Source: Eur Respir J 2003; 22: Suppl. 45, 39s Year: 2003
Suppressive effects of formoterol and salmeterol on eotaxin-1 in bronchial epithelial cells Source: Annual Congress 2008 - Novel therapeutic approaches and immunological mechanisms in airway cell pathobiology Year: 2008
Formoterol but not salmeterol enhances cytokine release Source: Eur Respir J 2002; 20: Suppl. 38, 619s Year: 2002
Effect of beclomethasone dipropionate, formoterol and their combination on TNF-α-induced ICAM-1 and IL-8 expression in human bronchial epithelial cells Source: Annual Congress 2012 - Molecular biology of pro- and anti-inflammatory responses in the lung Year: 2012
Allergen-induced airway decorin production is inhibited by budesonide and formoterol in a mouse model of asthma Source: Eur Respir J 2004; 24: Suppl. 48, 690s Year: 2004
Differences in efficacy between formoterol and salmeterol in relaxation of the mouse trachea are accentuated by inflammatory cytokines Source: Eur Respir J 2005; 26: Suppl. 49, 370s Year: 2005
A comparison of beta2 -adrenoceptor desensitisation induced by olodaterol and formoterol in human lung mast cells and airway smooth muscle cells Source: Annual Congress 2013 –New drugs in respiratory medicine Year: 2013
IL-1β-induced MCP-1 production in human airway smooth muscle cells, modulation by dexamethasone, rolipram, and salbutamol Source: Eur Respir J 2001; 18: Suppl. 33, 353s Year: 2001
Indacaterol/mometasone furoate combination: synergism in human hyperresponsive airway smooth muscle Source: Virtual Congress 2020 – Clinical and laboratory pharmacology in asthma Year: 2020
The inhibitory effect of formoterol and salmeterol on the IP-10 (CXCL10) in bronchial epithelial cells Source: Annual Congress 2009 - Models of chronic airways disease and therapy Year: 2009
Inhibition of allergen-induced airway remodelling by tiotropium and budesonide: a comparison Source: Eur Respir J 2007; 30: 653-661 Year: 2007
The PPARgamma agonist ciglitizone inhibits CXCL10 release by asthmatic and non-asthmatic airway smooth muscle cells Source: Eur Respir J 2006; 28: Suppl. 50, 339s Year: 2006
Role and regulation of interleukin-1 molecules in pro-asthmatic sensitised airway smooth muscle Source: Eur Respir J 2004; 24 : 559-567 Year: 2004
Formoterol and salmeterol enhance cytokine release in primary bronchial epithelial cells Source: Eur Respir J 2004; 24: Suppl. 48, 101s Year: 2004
Fluticasone and salmeterol downregulate in vitro, fibroblast proliferation and ICAM-1 or H-CAM expression Source: Eur Respir J 2001; 18: 139-145 Year: 2001
Inhaled budesonide induces corticosteroid-dependent gene expression in asthmatics: Validation in primary epithelial and airways smooth muscle cells Source: Annual Congress 2011 - Models of disease and drug actions Year: 2011